Sumatriptan Iontophoretic Transdermal System Reduces Treatment‐Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline – Results From a Randomized Controlled Trial期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Sumatriptan Iontophoretic Transdermal System Reduces Treatment‐Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline – Results From a Randomized Controlled Trial

Authors:	Marcelo E Bigal MD PhD Richard B Lipton MD Lawrence C Newman MD Mark W Pierce MD Stephen D Silberstein MD

Institution:	1. Migraine and Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA, USA;2. Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA;3. Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA;4. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA;5. Headache Institute, St. Luke's‐Roosevelt Hospital Center, New York, NY, USA;6. NuPathe Inc., Conshohocken, PA, USA;7. Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA;8. Jefferson Hospital for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA

Abstract:

Keywords:	sumatriptan transdermal system zecuity